Artemis Global Life Sciences Limited announced audited standalone earnings results for the fourth quarter and full year and consolidated earnings results for the year ended March 31, 2018. For the quarter, on standalone basis, the company reported revenue from operations of INR 1.020 million against INR 1.020 million a year ago. Loss from operations before exceptional items and tax was INR 0.624 million against profit of INR 0.282 million a year ago. Loss from ordinary activities before tax was INR 0.585 million against profit of INR 0.282 million a year ago. Net loss was INR 1.751 million against profit of INR 0.124 million a year ago. Basic and diluted loss per share was INR 0.03. For the year, on standalone basis, the company reported revenue from operations of INR 4.080 million against INR 4.080 million a year ago. Loss from operations before exceptional items and tax was INR 2.682 million against profit of INR 2.112 million a year ago. Loss from ordinary activities before tax was INR 3.781 million against profit of INR 2.112 million a year ago. Net loss was INR 2.988 million against profit of INR 1.481 million a year ago. Basic and diluted loss per share was INR 0.05 against earnings per share of INR 0.02 a year ago. For the year, on consolidated basis, the company reported revenue from operations of INR 5,027.871 million against INR 4,633.049 million a year ago. Profit from operations before exceptional items and tax was INR 350.142 million against INR 325.599 million a year ago. Profit from ordinary activities before tax was INR 349.043 million against INR 325.599 million a year ago. Net profit was INR 262.763 million against INR 271.149 million a year ago. Basic and diluted earnings per share were INR 3.97 against INR 4.10 per share a year ago.